- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04859972
How Well do Primary Care Doctors in Region Örebro County, Sweden Follow Diagnostic Guidelines of IBS?
Adherence of Primary Care Doctors to Guidelines of Making a Positive Diagnosis of IBS.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder. To diagnose IBS, the so-called Rome Criteria combined with limited laboratory tests should be used. However, within the primary care, too much unnecessary diagnostics, for example radiology and endoscopy, are used. This is meaningless, stressful for the patient and they also cost a lot of money.
In Örebro Region there are 29 public general health centers. Approximately 300.000 inhabitants are listed within these health centers. Approximately 150 doctors are currently working within the primary health care of Örebro Region. The software program Medrave and the electronic patient register in Örebro Region allows to search for the International Statistical Classification of Diseases (ICD-10) for IBS (K58.9 and K58.0) This allows retrospective research regarding diagnosing IBS, the used diagnostic tools, comorbidities, as well as the different treatments that were used.
Patients diagnosed with IBS will be identified by ICD-code K.58. By evaluating their patient register it will be determined how the GP has made the IBS diagnosis. Patients will fall into three categories: those who received a positive IBS diagnosis using the Rome criteria, those who received a negative IBS diagnosis and those whose patient record is lacking sufficient information.
Data will also include demographics, number of GP contacts and referrals to specialists, diagnostic procedures, treatments, and relevant somatic, psychological and psychiatric comorbidities. Data regarding substance abuse will be collected as well.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Jussi Rauma, Ph.D. student, M.D.
- Phone Number: +46702484167
- Email: jussi.rauma@regionorebrolan.se
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
• All adult patients (both sexes) who were diagnosed with IBS according to ICD-10 in Region Örebro County 2015-2019.
Exclusion Criteria:
• Patients < 18 years or > 65 years
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients diagnosed with IBS
Patients diagnosed with IBS within primary care in Region Örebro County between 2015- 2019, identified by ICD-code K.58.
|
Diagnosis of IBS according to ICD-10
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to guidelines of making a positive diagnosis of IBS within primary care.
Time Frame: 2015-2019
|
The proportion of patients that received a positive IBS diagnosis versus the proportion of patients that received a negative IBS diagnosis.
|
2015-2019
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of diarrhea-predominant IBS and IBS without diarrhea.
Time Frame: 2015-2019
|
Proportion of patients with diarrhea-predominant IBS versus IBS without diarrhea
|
2015-2019
|
The proportion of IBS patients that have one or more comorbidities.
Time Frame: 2015-2019
|
Data will be collected about the following comorbidities: depression (F32, F33 and F41.2), anxiety (F41), somatization syndrome (F45), posttraumatic stress syndrome (F43.1),
sleeping disorder (G47.9),
urinary incontinence (N39.3 and N39.4), fecal incontinence (R15.9),
migraine (G43), headache (R51.9 and G44.2), menstruation symptoms (N92 and N94), fibromyalgia (M79.7),
Ehlers Danlos syndrome (Q79.6), other unspecific muskuloskeletal pain (M79) and functional dyspepsia (K30.9).
|
2015-2019
|
The proportion of IBS patients with post-infectious IBS.
Time Frame: 2015-2019
|
The presence of gastroenteritis (A09.9) that precedes the diagnosis of IBS.
|
2015-2019
|
The proportion of IBS patients with substance abuse.
Time Frame: 2015-2019
|
Data will be collected regarding substance abuse which is defined by alcohol (F10), opioids (F11), cannabis (F12), sedatives and hypnotics (F13) and Tobacco (F17).
|
2015-2019
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michiel van Nieuwenhoven, Associate Professor, M.D. PhD., Region Örebro County
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 277069
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Irritable Bowel Syndrome
-
ProgenaBiomeRecruitingIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome Characterized by Constipation | Irritable Bowel Syndrome Mixed | Irritable Bowel Syndrome Without Diarrhea | Irritable Bowel | Irritable Bowel Syndrome Aggravated and other conditionsUnited States
-
Istanbul Medipol University HospitalTepecik Training and Research Hospital; Bozyaka Training and Research Hospital and other collaboratorsRecruitingIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedTurkey
-
ClasadoCR2O B.V.RecruitingIrritable Bowel Syndrome | Irritable Bowel Syndrome - Constipation | Irritable Bowel Syndrome - Diarrhoea | Irritable Bowel Syndrome - MixedBelgium, Netherlands, United Kingdom
-
Federal Stare Budgetary Scientific Institution,...I.M. Sechenov First Moscow State Medical University; RML INVEST, Torkhovsky...CompletedIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedRussian Federation
-
University of California, Los AngelesCompletedIrritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Mixed Bowel HabitsUnited States
-
University of ViennaCompleted
-
Thomayer University HospitalCharles University, Czech RepublicActive, not recruitingIrritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome MixedCzechia
-
Shahid Beheshti University of Medical SciencesCompletedIrritable Bowel DiseaseIran, Islamic Republic of
-
Universidad Autonoma de ChihuahuaNot yet recruitingIrritable Bowel Syndrome | Constipation-predominant Irritable Bowel Syndrome | Diarrhea- Irritable Bowel Syndrome
-
Vasily IsakovRussian Science Foundation; Azbuka vkusa; Federal Research Centre of Nutrition...CompletedIrritable Bowel Syndrome With Constipation | Constipation-predominant Irritable Bowel SyndromeRussian Federation
Clinical Trials on Diagnosis of IBS
-
University of California, Los AngelesNational Institute of Nursing Research (NINR)CompletedIrritable Bowel Syndrome
-
Sahlgrenska University Hospital, SwedenCompletedIrritable Bowel SyndromeSweden
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruiting
-
University of ConnecticutYale UniversityNot yet recruiting
-
Aboca Spa Societa' AgricolaIQVIA RDS; IQVIA SolutionsCompletedIrritable Bowel SyndromeItaly, Germany
-
Nova Scotia Health AuthorityResearch Nova ScotiaRecruitingIBS - Irritable Bowel SyndromeCanada
-
Queen's UniversityUnknownIrritable Bowel Syndrome | Visceral HypersensitivityCanada
-
Biokuris s.a.RecruitingIrritable Bowel SyndromeBelgium
-
University of ConnecticutNational Institute of Nursing Research (NINR)CompletedIrritable Bowel SyndromeUnited States
-
University of California, Los AngelesBodiMojo, Inc.CompletedIrritable Bowel Syndrome | Abdominal PainUnited States